42.44
0.82%
-0.35
After Hours:
42.44
Genedx Holdings Corp stock is traded at $42.44, with a volume of 580.77K.
It is down -0.82% in the last 24 hours and up +32.87% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
See More
Previous Close:
$42.79
Open:
$43.11
24h Volume:
580.77K
Relative Volume:
1.30
Market Cap:
$1.15B
Revenue:
$202.57M
Net Income/Loss:
$-175.77M
P/E Ratio:
-1.1935
EPS:
-35.5597
Net Cash Flow:
$-185.86M
1W Performance:
+5.76%
1M Performance:
+32.87%
6M Performance:
+364.84%
1Y Performance:
+1,066%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
617 780 8742
Address
333 LUDLOW STREET, STAMFORD
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx (NASDAQ:WGS) Reaches New 52-Week High at $43.61 - MarketBeat
Driehaus Capital Management LLC Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Rhumbline Advisers Grows Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Rhumbline Advisers Grows Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Taking a look at what insiders are doing to gauge the GeneDx Holdings Corp (WGS)’s direction - Knox Daily
Stock Performance Spotlight: GeneDx Holdings Corp (WGS) Ends the Day at 36.84, Down by -5.71 - The Dwinnex
Alpha DNA Investment Management LLC Takes $363,000 Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Positive Signs As Multiple Insiders Buy GeneDx Holdings Stock - Simply Wall St
Oracle Investment Management Inc. Has $28.91 Million Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
How to Take Advantage of moves in (WGS) - Stock Traders Daily
Genius Sports Limited (NYSE:GENI) Shares Bought by Hood River Capital Management LLC - Defense World
VanEck Gold Miners ETF (NYSEARCA:GDX) Sets New 52-Week High at $41.10 - Defense World
Views of Wall Street’s Leading Experts on GeneDx Holdings Corp - SETE News
Discovery Capital Management LLC CT Sells 231,999 Shares of Genius Sports Limited (NYSE:GENI) - MarketBeat
Leerink Partnrs Analysts Lift Earnings Estimates for Genfit S.A. (NASDAQ:GNFT) - Defense World
GEELY's ZEEKR Has First Mid-size SUV Hit Mkt; Price Cut to RMB229,900 - AASTOCKS.com
Renaissance Technologies LLC Sells 166,200 Shares of Gentex Co. (NASDAQ:GNTX) - Defense World
Mercer Global Advisors Inc. ADV Reduces Holdings in VanEck Gold Miners ETF (NYSEARCA:GDX) - Defense World
Bank of New York Mellon Corp Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Federated Hermes Inc. Lowers Stock Position in Gentex Co. (NASDAQ:GNTX) - Defense World
King Luther Capital Management Corp Decreases Stake in Gentex Co. (NASDAQ:GNTX) - Defense World
GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Massachusetts Financial Services Co. MA Has $37.22 Million Position in Genius Sports Limited (NYSE:GENI) - Defense World
Divisadero Street Capital Management LP Invests $5.89 Million in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Stock Traders Buy Large Volume of Genius Sports Call Options (NYSE:GENI) - Defense World
GeneDx CFO sells over $99k in company stock By Investing.com - Investing.com Australia
GeneDx (NASDAQ:WGS) Sets New 1-Year High at $40.80 - MarketBeat
GeneDx Holdings Corp (WGS) Shares Up 3.59% on Sep 19 - GuruFocus.com
This Biotech Stock's Quadruple-Digit Turnaround To The Top 1% - Investor's Business Daily
GeneDx CEO Katherine Stueland sells over $394k in company stock - Investing.com Australia
GeneDx (NASDAQ:WGS) Trading 7.6% Higher - MarketBeat
GeneDx CEO Katherine Stueland sells over $394k in company stock By Investing.com - Investing.com South Africa
GeneDx CFO sells over $99k in company stock By Investing.com - Investing.com Canada
GeneDx CEO Katherine Stueland sells over $394k in company stock - Investing.com
GeneDx CFO sells over $99k in company stock - Investing.com India
GeneDx CFO sells over $99k in company stock - Investing.com
Analysts review Genius Sports Limited’s rating - Knox Daily
Market Watch Highlights: Genius Sports Limited (GENI) Ends on an Downturn Note at 7.55 - The Dwinnex
Choreo LLC Takes Position in Gentex Co. (NASDAQ:GNTX) - Defense World
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Expands By 17.5% - Defense World
GeneDx (NASDAQ:WGS) Reaches New 12-Month High at $38.76 - MarketBeat
A Tale of Resilience: GeneDx Holdings Corp Amid Stock Market Turbulence - The InvestChronicle
GeneDx (NASDAQ:WGS) Stock Price Up 5.7% - MarketBeat
GeneDx Holdings CEO sells over $121k in stock - Investing.com India
Kevin Feeley Sells 895 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
GeneDx CFO sells shares worth over $29k to cover tax obligations - Investing.com
GeneDx CFO sells shares worth over $29k to cover tax obligations - Investing.com Canada
GeneDx Holdings CEO sells over $121k in stock - Investing.com
GeneDx CFO sells shares worth over $29k to cover tax obligations - Investing.com UK
WGS (GeneDx Holdings Corp) may reap gains as insiders became active recently - Knox Daily
GeneDx (NASDAQ:WGS) Trading Up 6.6% - MarketBeat
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Stueland Katherine | Chief Executive Officer |
Sep 16 '24 |
Option Exercise |
0.00 |
18,750 |
0 |
114,207 |
Stueland Katherine | Chief Executive Officer |
Sep 16 '24 |
Sale |
37.59 |
10,501 |
394,733 |
103,706 |
Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 16 '24 |
Option Exercise |
0.00 |
7,197 |
0 |
47,107 |
Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 16 '24 |
Sale |
37.59 |
2,635 |
99,050 |
44,472 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):